Handheld fractional exhaled nitric oxide (FeNO) monitors — the portable, electrochemical sensor-based devices measuring airway inflammation at ppb levels in 10 seconds at the point-of-care — represent the fastest-growing segment in the respiratory diagnostics market, with the Feno Monitor Market reflecting handheld FeNO as the asthma phenotype-guided therapy commercial driver....